EVR Research’s Concentrix CNXC Stock Holding History

EVR Research’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-240,000	Closed	-$15.9M	–	33
2024 Q1	$15.9M	Buy	+240,000	New	+$19.5M	3.55%	12

Other funds holding CNXC

GBL

Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

EVR Research's CNXC Position: Q2 2024 in Review

EVR Research sold out of Concentrix (CNXC) in Q2 2024, closing a stake of 240,000 shares — an estimated $15.9M sold.

EVR Research first reported a position in CNXC in Q1 2024 and held it in 1 quarter. The position peaked at $15.9M in Q1 2024. 297 funds tracked by Wall St. Rank hold CNXC as of Q2 2024.

EVR Research reported no remaining Concentrix position as of Q2 2024 after selling out during the quarter.
EVR Research sold 240,000 Concentrix shares in Q2 2024, an estimated $15.9M.
EVR Research first reported a position in Concentrix in Q1 2024 and held it in 1 quarter.
EVR Research's Concentrix position peaked at $15.9M in Q1 2024.
297 funds tracked by Wall St. Rank held Concentrix as of Q2 2024.

Based on EVR Research's 13F filing for Q2 2024, filed 14 Aug 2024.